Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast CancerSara Alkner, Mårten Fernö|PLoS ONE|2016Cited by 11
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breastUlrik Narbe, Mårten Fernö|Breast Cancer Research and Treatment|2019Cited by 9